logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On April 2, CHAOJU EYE CARE (02219) spent 27,200 Hong Kong dollars to repurchase 10,000 shares.

date
20:07 02/04/2026
avatar
GMT Eight
In the morning of April 2, 2026, Chaoju Eye Care (02219) announced that it would spend HKD 27,200 to repurchase 10,000 shares.
CHAOJU Eye Care (02219) announces that it will spend HK$27,200 to repurchase 10,000 shares on April 2, 2026.
Related Articles
HK Stock
DUFU LIQUOR GP (00986) plans to implement a equity restructuring and change in the minimum trading unit.
New Stock News | Suzhou UIGreen Micro & Nano Technologies (688661.SH) Once Again Files Listing Application with Hong Kong Stock Exchange
HK Stock
JIUYUAN GENE (02566) has completed the filing with the China Securities Regulatory Commission regarding the full circulation of H shares.
DUFU LIQUOR GP (00986) plans to implement a equity restructuring and change in the minimum trading unit.
HK Stock
New Stock News | Suzhou UIGreen Micro & Nano Technologies (688661.SH) Once Again Files Listing Application with Hong Kong Stock Exchange
JIUYUAN GENE (02566) has completed the filing with the China Securities Regulatory Commission regarding the full circulation of H shares.
HK Stock
RECOMMEND
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
icon
02/04/2026
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
icon
02/04/2026
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
icon
02/04/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.